This Article Order Full text via Infotrieve Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheng, S. W. Articles by Berecek, K. H. Search for Related Content PubMed PubMed Citation Articles by Cheng, S. W. Articles by Berecek, K. H.

Hypertension, Vol 13, 63-69, Copyright © 1989 by American Heart Association

ARTICLES

Baroreflex function in lifetime-captopril-treated spontaneously hypertensive rats

SW Cheng, BH Swords, KA Kirk and KH Berecek
Department of Physiology and Biophysics, University of Alabama, Birmingham 35294.

The effects of lifetime oral captopril treatment on baroreflex control of heart rate and lumbar sympathetic nerve activity were measured in 19- 21-week-old spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY). The sensitivity of baroreflex control of heart rate and lumbar sympathetic nerve activity were determined by the slopes of the relation between the change in mean arterial pressure (MAP) (mm Hg) versus the change in pulse interval (msec/beat) and the change in MAP versus the percent change in nerve activity, respectively. Untreated SHR had significantly higher MAP than WKY (157 +/- 3 vs. 115 +/- 3 mm Hg, p less than 0.001) and exhibited a decreased baroreflex control of heart rate. Lifetime treatment with captopril prevented the development of hypertension in SHR (MAP = 110 +/- 5 mm Hg) and increased the sensitivity of baroreflex function. The gains of the baroreflex control of heart rate for captopril-treated SHR and control SHR when MAP was raised or lowered by phenylephrine or nitroprusside were 2.38 +/- 0.49 vs. 1.10 +/- 0.33 msec/mm Hg (p less than 0.05) and 0.74 +/- 0.20 vs. 0.54 +/- 0.09 (NS) msec/mm Hg, respectively. The sensitivity of the baroreflex control of lumbar sympathetic nerve activity was greater in captopril-treated SHR than in control SHR when MAP was increased or decreased (-1.03 +/- 0.26 vs. -0.38 +/- 0.11, p less than 0.05; -0.84 +/- 0.2 vs. -0.04 +/- 0.58 (NS) mm Hg-1, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				D. W. CARLEY, K. BERECEK, A. VIDENOVIC, and M. RADULOVACKI Sleep-disordered Respiration in Phenotypically Normotensive, Genetically Hypertensive Rats Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1474 - 1479. [Abstract] [Full Text] [PDF]

				J. Zicha and J. Kunes Ontogenetic Aspects of Hypertension Development: Analysis in the Rat Physiol Rev, October 1, 1999; 79(4): 1227 - 1282. [Abstract] [Full Text] [PDF]

				K. Matsumura, D. B. Averill, and C. M. Ferrario Angiotensin II acts at AT1 receptors in the nucleus of the solitary tract to attenuate the baroreceptor reflex Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1998; 275(5): R1611 - R1619. [Abstract] [Full Text] [PDF]

				P. Lantelme, C. Cerutti, M. Lo, C. Z. Paultre, and M. Ducher Mechanisms of spontaneous baroreflex impairment in Lyon hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1998; 275(3): R920 - R925. [Abstract] [Full Text] [PDF]

				D. R. Oliveira, R. A.S. Santos, G. F.P. Santos, M. C. Khosla, and M. J. Campagnole-Santos Changes in the Baroreflex Control of Heart Rate Produced by Central Infusion of Selective Angiotensin Antagonists in Hypertensive Rats Hypertension, June 1, 1996; 27(6): 1284 - 1290. [Abstract] [Full Text]